Bravetti, Giorgio Enrico http://orcid.org/0000-0002-4756-8715
Gillmann, Kevin
Salinas, Lauriane
Berdahl, John P.
Lazcano-Gomez, Gabriel S.
Williamson, Blake K.
Dorairaj, Syril K.
Seibold, Leonard K.
Smith, Sanjay
Aref, Ahmad A.
Darlington, Jason K.
Jimenez-Roman, Jesus
Mahootchi, Ahad
Mansouri, Kaweh
Article History
Received: 14 May 2021
Revised: 25 June 2022
Accepted: 27 July 2022
First Online: 9 August 2022
Competing interests
: JPB: Alcon, Allergan, Bausch and Lomb, CorneaGen, Dakota Lions Eye Bank, Equinox, Expert Opinion, Glaucos, Gore, Imprimis/Harrow Health, JNJ, Kala, Kedalion, MELT Pharmaceuticals, MicroOptix, New World Medical, Ocular Surgical Data, Ocular Theraputix, Omega Ophthalmic, Orasis, Oyster Point, RxSight, Surface Inc., Tarsus, Tear Clear, Vittamed, Vance Thompson Vision, Verana Health (Digisight), Visionary Ventures, Zeiss. Lazcano-Gomez GSL-G: New World Medical. BKW: New World Medical. SKD: New World Medical, Iridex. LS: New World Medical. AAA: New World Medical, Aerie Pharmaceuticals, Bausch and Lomb. AM: Allergan, Bausch and Lomb, Iridex, New World Medical. KM: Santen, Sensimed, Topcon, Alcon, Allergan, Optovue, ImplantData. Others: no financial disclosures.